Marko Busic v. Orphazyme A/S et al: Class Action Complaint

Class Action Complaint alleging securities fraud in Marko Busic v. Orphazyme A/S, of Denmark, described as “a biopharmaceutical company that develops therapies for the treatment of neurodegenerative orphan diseases”; Christophe Bourdon, Kim Stratton, Anders Vadsholt, Thomas Blaettler, Molly Painter, Georges Gemayel, Bo Jesper Hansen, Martin Bonde, Rémi Droller, Sten Verland, Martijn Kleijwegt, Anders Hedegaard, Catherine Moukheibir, and Carrolee Barlow at the U. S. District Court for the Northern District of Illinois.